Real ChatGPT answer · index seedcFYiO9ViqJ0completeHealth and wellness · women's healthinformational
I am sixty-two and considering hormone replacement therapy for vaginal dryness, but I need a breakdown of current research comparing oral pills versus transdermal patches for safety.
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
I am sixty-two and considering hormone replacement therapy for vaginal dryness, but I need a breakdown of current research comparing oral pills versus transdermal patches for safety.
4 real searches · 1 real-search pass
2024 2025 evidence oral versus transdermal menopausal hormone therapy venous thromboembolism stroke systematic review guidelineGoogle ↗
OBSERVED
The Menopause Society 2022 hormone therapy position statement age 60 10 years since menopause transdermal vaginal genitourinary syndromeGoogle ↗
OBSERVED
ACOG vaginal estrogen genitourinary syndrome menopause low dose systemic absorption progestin 2024Google ↗
OBSERVED
NICE menopause guideline oral transdermal HRT venous thromboembolism stroke breast cancer vaginal estrogenGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 4 queries…
Searches and sources
ChatGPT4 real searches · gpt-6
2024 2025 evidence oral versus transdermal menopausal hormone therapy venous thromboembolism stroke systematic review guideline Google ↗
The Menopause Society 2022 hormone therapy position statement age 60 10 years since menopause transdermal vaginal genitourinary syndrome Google ↗
ACOG vaginal estrogen genitourinary syndrome menopause low dose systemic absorption progestin 2024 Google ↗
NICE menopause guideline oral transdermal HRT venous thromboembolism stroke breast cancer vaginal estrogen Google ↗
- Safety of menopause hormone therapy in postmenopausal women at higher risk of venous thromboembolism: a systematic review · pubmed.ncbi.nlm.nih.gov
- Comparative Evidence Between Transdermal and Oral Menopausal Hormone Therapy · ncbi.nlm.nih.gov
- The 2022 hormone therapy position statement of The North American Menopause Society · pubmed.ncbi.nlm.nih.gov
- Recommendations | Menopause: identification and management | Guidance · nice.org.uk
- NAMS Hormone Therapy Position Statement 2022 Guideline Summary · guidelinecentral.com
- Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline · auanet.org
- Executive Summary: The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause. · pubmed.ncbi.nlm.nih.gov
- The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society · pubmed.ncbi.nlm.nih.gov
- Menopause - Gynecology and Obstetrics · merckmanuals.com
- FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies · fda.gov
Queries
4 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2024 2025 evidence oral versus transdermal menopausal hormone therapy venous thromboembolism stroke systematic review guideline OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
The Menopause Society 2022 hormone therapy position statement age 60 10 years since menopause transdermal vaginal genitourinary syndrome OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
ACOG vaginal estrogen genitourinary syndrome menopause low dose systemic absorption progestin 2024 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
NICE menopause guideline oral transdermal HRT venous thromboembolism stroke breast cancer vaginal estrogen OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |